The effect of beta blocker use on bone outcomes using the Framingham Osteoporosis Study
Maine Medical Center Research Institute, Center for Outcomes Research and Evealuation
Adrenergic beta-Antagonists, Osteoporosis
Bone fragility contributes to significant morbidity and mortality, increased medical costs, and decreased quality of life
-Over five billion dollars in annual hospital costs for older US women
-more costly that breast cancer, stroke, and myocardial infraction
Beta blockers (BBs) which competitively antagonize receptors in the sympathetic nervous system (SNS), improve bone metabolism and offer therapeutic benefit to patients at high risk of fracture.
Lary, Christine, "The effect of beta blocker use on bone outcomes using the Framingham Osteoporosis Study" (2019). Maine Medical Center. 715.